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This is mainly due to the lower average number of treatment
cycles needed with zoledronic acid 5mg, also considering the
improved compliance with the IV infusion. The probabilistic sen-
sitivity analyses performed show that the results are robust.
CONCLUSION: Based on our evaluation, in PDB, zoledronic
acid 5mg is both more effective and less costly than the other
bisphosphonates currently reimbursed in Belgium.
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OBJECTIVES: The objective of this study was to develop a ﬂex-
ible health economic simulation Markov cohort model that can
be used to assess the cost-effectiveness of different treatment
strategies within the hip and knee arthroplasty area in Sweden.
METHODS: The Markov cohort model included the following
health states: No event, Revision, re-revision and dead. The
model have stochastic capabilities and the uncertainty in the risk
of revision, mortality after revision, costs and quality of life were
accounted for by bootstrapping technique. For exempliﬁcation
the model was used to estimate the cost-effectiveness of a
cemented implants with antibiotics compared to cemented
implants without antibiotics in a Swedish setting for both
patients with THA and TKA. Data used to populate the model
was mainly derived from the Swedish National Hip Arthroplasty
Register and the Swedish Knee Arthroplasty Register and the
Swedish National Inpatient Register. The analysis had a societal
perspective (i.e. the aim is to include all relevant costs irrespec-
tive of who incur them). In the base case simulations patient were
followed for 10 years after the arthroplasty. RESULTS: An
antibiotic cemented implant compared to an implant without
antibiotics was found cost saving both for patients having a THA
and TKA was found to be cost saving when patients were fol-
lowed for 10 years after the procedure in the model. When the
costs in added life were included the cost per QALY gained was
SEK 187,888 for THA and SEK 186,217 for TKA. CONCLU-
SIONS: The developed cost-effectiveness model indicated that
antibiotic cemented implants compared to implants with no
antibiotics was cost-effective for the use in THA and TKA. The
model is highly adaptable for the evaluation of other treatments
strategies such as prostheses but it can also be used to evaluate
waiting times or the procedure as a whole.
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OBJECTIVES: To examine trends of prevalence and treatment
patterns of diabetes mellitus (DM) in adults and to determine the
relationship between DM and obesity. METHODS: This study
used Third National Health and Nutrition Examination Survey
(NHANES III for 1988–1994) and NHANES 1999–2002, rep-
resenting a national sample of the non-institutionalized civilian
US population. Adult DM patients were identiﬁed if they were
≥20 years old, and were previously diagnosed with DM by a
physician or currently using DM therapy (hypoglycemic
agent/insulin). These patients were classiﬁed as obese if body
mass index ≥30. Nationally representative prevalence was esti-
mated using sample weights. Data were analyzed using SAS and
SUDAAN statistical softwares to adjust for the complex sample
design. RESULTS: The age-adjusted prevalence of DM was 6.8%
in 1999–2002 compared to 5.4% in 1988–1994 (p < 0.001).
Approximately 51.6% of DM patients were obese in 1999–2002
(44.1% in 1988–1994). During 1999–2002, DM was more
prevalent in patients aged 65–74 (16.31%) and was increased
most rapidly in this age group (4.5% increase; p < 0.05). DM
was most prevalent in Whites (61%; 12.7% decrease from
NHANES-III; p < 0.05), followed by Blacks (16%; 1% increase),
and Hispanics (16%; 10% increase; p < 0.05). More obese DM
patients were treated with medication than non-obese DM
patients (84% vs. 80%). During study period, DM patients who
received treatment signiﬁcantly increased by 8% (p < 0.01; 6%
in obese), but 62% of these patients’ A1c was still uncontrolled.
DM patients often have comorbidities of hypertension (67%;
4% increase), followed by hyperlipidemia (48%; 12% increase),
and retinopathy (27%; 11% increase) and these comorbidities
are more prevalent in obese DM patients. CONCLUSIONS: DM
has become very rapidly prevalent in US adults, with the great-
est increase in Hispanics. Approximately half of DM patients did
not have their A1C level controlled and one-ﬁfth still did not
receive treatment. DM patients who were obese were less likely
to control their A1c compared to overall DM patients.
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OBJECTIVES: To estimate prevalence trends of overweight and
obesity and to assess relationship between weight status and
physical activity in adults ≥20 years old. METHODS: Three
National Health and Nutrition Examination Surveys, NHANES
(II) for 1976–1980, NHANES (III) for 1988–1994, and
NHANES (IV) 1999–2002 were used. Based on body mass index
(BMI), adults were classiﬁed as overweight (BMI 25 to <30) or
obese (BMI ≥ 30). Duration of physical activity was calculated
using leisure-time physical activity to determine compliance of
CDC recommendations. SAS and SUDAAN softwares were used
to account for the complex survey designs. RESULTS: The mean
BMI increased from 25.31(II) to 28.02(IV). During the study
period of II–IV, the prevalence of overweight and obesity
changed from 31.4% to 34.7% and from 14.5% to 30.2%,
respectively. Obesity signiﬁcantly increased 7.8% for II–III (p <
0.001) and 7.9% for III–IV (p < 0.001). The prevalence of over-
weight individuals increased most rapidly in adults 20–39 years
old. Obesity increased most rapidly in patients 40–64 years old
for II–III and 20–39 years old for III–IV. Hypertension was more
prevalent in obesity (75.2%(II), 50.7%(III), 48.0%(IV)) than
overweight (54.5%(II), 33.7%(III), 34.1%(IV)), yet for both
groups decreased over time. During IV, overweight adults spent
an average of 240 minutes per week for physical activity, and
obese adults spent 170 minutes. Only 43.2% of overweight and
37.5% of obese took medications or followed physical activity
guideline to control weight. CONCLUSIONS: Two-thirds of
U.S. adults were considered to be overweight or obese. The
prevalence of overweight and obesity continuously increased
during the past 30 years and increased more rapidly in recent
years. It is recommended that aggressive interventions be initi-
ated to increase patient awareness so that more patients get
treated and follow physical activity guidelines to lose or control
weight.
